A novel epithelial‐mesenchymal transition molecular signature predicts the oncological outcomes in colorectal cancer
Epithelial‐mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour initiation and metastasis. The aim of this study was to construct an EMT molecular signature for predicting colorectal cancer (CRC) prognosis and eva...
Saved in:
Published in | Journal of cellular and molecular medicine Vol. 25; no. 7; pp. 3194 - 3204 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
John Wiley & Sons, Inc
01.04.2021
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Epithelial‐mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour initiation and metastasis. The aim of this study was to construct an EMT molecular signature for predicting colorectal cancer (CRC) prognosis and evaluate the efficacy of the model. The risk scoring system, constructed by log‐rank test and multivariate Cox regression analysis according to EMT‐related gene expression in CRC patients from TCGA database, demonstrated the highest correlation with prognosis compared with other parameters in CRC patients. The risk scores were significantly correlated with more lymph node metastasis, distal metastasis and advanced clinical stage of CRC. The model was further successfully validated in two independent external cohorts from GEO database. Furthermore, we developed a nomogram to integrate the EMT signature with the pathological stage of CRC, which was found to perform well in predicting the overall survival. Additionally, this risk scoring model was found to be associated with immune cell infiltration, implying a potential role of EMT involved in immunity regulation in tumour microenvironment. Taken together, our novel EMT molecular model may be useful in identifying high‐risk patients who need an intensive follow‐up and more aggressive therapy, finally contributing to more precise individualized therapeutic strategies. |
---|---|
AbstractList | Epithelial‐mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour initiation and metastasis. The aim of this study was to construct an EMT molecular signature for predicting colorectal cancer (CRC) prognosis and evaluate the efficacy of the model. The risk scoring system, constructed by log‐rank test and multivariate Cox regression analysis according to EMT‐related gene expression in CRC patients from TCGA database, demonstrated the highest correlation with prognosis compared with other parameters in CRC patients. The risk scores were significantly correlated with more lymph node metastasis, distal metastasis and advanced clinical stage of CRC. The model was further successfully validated in two independent external cohorts from GEO database. Furthermore, we developed a nomogram to integrate the EMT signature with the pathological stage of CRC, which was found to perform well in predicting the overall survival. Additionally, this risk scoring model was found to be associated with immune cell infiltration, implying a potential role of EMT involved in immunity regulation in tumour microenvironment. Taken together, our novel EMT molecular model may be useful in identifying high‐risk patients who need an intensive follow‐up and more aggressive therapy, finally contributing to more precise individualized therapeutic strategies. Epithelial-mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour initiation and metastasis. The aim of this study was to construct an EMT molecular signature for predicting colorectal cancer (CRC) prognosis and evaluate the efficacy of the model. The risk scoring system, constructed by log-rank test and multivariate Cox regression analysis according to EMT-related gene expression in CRC patients from TCGA database, demonstrated the highest correlation with prognosis compared with other parameters in CRC patients. The risk scores were significantly correlated with more lymph node metastasis, distal metastasis and advanced clinical stage of CRC. The model was further successfully validated in two independent external cohorts from GEO database. Furthermore, we developed a nomogram to integrate the EMT signature with the pathological stage of CRC, which was found to perform well in predicting the overall survival. Additionally, this risk scoring model was found to be associated with immune cell infiltration, implying a potential role of EMT involved in immunity regulation in tumour microenvironment. Taken together, our novel EMT molecular model may be useful in identifying high-risk patients who need an intensive follow-up and more aggressive therapy, finally contributing to more precise individualized therapeutic strategies.Epithelial-mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour initiation and metastasis. The aim of this study was to construct an EMT molecular signature for predicting colorectal cancer (CRC) prognosis and evaluate the efficacy of the model. The risk scoring system, constructed by log-rank test and multivariate Cox regression analysis according to EMT-related gene expression in CRC patients from TCGA database, demonstrated the highest correlation with prognosis compared with other parameters in CRC patients. The risk scores were significantly correlated with more lymph node metastasis, distal metastasis and advanced clinical stage of CRC. The model was further successfully validated in two independent external cohorts from GEO database. Furthermore, we developed a nomogram to integrate the EMT signature with the pathological stage of CRC, which was found to perform well in predicting the overall survival. Additionally, this risk scoring model was found to be associated with immune cell infiltration, implying a potential role of EMT involved in immunity regulation in tumour microenvironment. Taken together, our novel EMT molecular model may be useful in identifying high-risk patients who need an intensive follow-up and more aggressive therapy, finally contributing to more precise individualized therapeutic strategies. |
Author | Li, Xinxiang Yan, Xuebing Shan, Zezhi Luo, Dakui Ma, Yanlei Yang, Yongzhi Goel, Ajay Wu, Wen Liu, Qi |
AuthorAffiliation | 1 Department of Colorectal Surgery Fudan University Shanghai Cancer Center Shanghai China 4 Department of Oncology the Affiliated Hospital of Yangzhou University Yangzhou University Yangzhou China 5 Department of Molecular Diagnostics and Experimental Therapeutics Beckman Research Institute of City of Hope Comprehensive Cancer Center Duarte CA USA 2 Department of Oncology Shanghai Medical College Fudan University Shanghai China 3 Department of Surgery Shanghai Pudong Hospital (Fudan University Pudong Medical Center) Shanghai China |
AuthorAffiliation_xml | – name: 4 Department of Oncology the Affiliated Hospital of Yangzhou University Yangzhou University Yangzhou China – name: 3 Department of Surgery Shanghai Pudong Hospital (Fudan University Pudong Medical Center) Shanghai China – name: 2 Department of Oncology Shanghai Medical College Fudan University Shanghai China – name: 5 Department of Molecular Diagnostics and Experimental Therapeutics Beckman Research Institute of City of Hope Comprehensive Cancer Center Duarte CA USA – name: 1 Department of Colorectal Surgery Fudan University Shanghai Cancer Center Shanghai China |
Author_xml | – sequence: 1 givenname: Zezhi surname: Shan fullname: Shan, Zezhi organization: Fudan University – sequence: 2 givenname: Wen surname: Wu fullname: Wu, Wen organization: Shanghai Pudong Hospital (Fudan University Pudong Medical Center) – sequence: 3 givenname: Xuebing surname: Yan fullname: Yan, Xuebing organization: Yangzhou University – sequence: 4 givenname: Yongzhi surname: Yang fullname: Yang, Yongzhi organization: Fudan University – sequence: 5 givenname: Dakui surname: Luo fullname: Luo, Dakui organization: Fudan University – sequence: 6 givenname: Qi orcidid: 0000-0002-7121-8563 surname: Liu fullname: Liu, Qi organization: Fudan University – sequence: 7 givenname: Xinxiang surname: Li fullname: Li, Xinxiang email: yanleima@fudan.edu.cn, 1149lxx@sina.com, ajgoel@coh.org organization: Fudan University – sequence: 8 givenname: Ajay surname: Goel fullname: Goel, Ajay email: ajgoel@coh.org organization: Beckman Research Institute of City of Hope Comprehensive Cancer Center – sequence: 9 givenname: Yanlei orcidid: 0000-0002-0632-5258 surname: Ma fullname: Ma, Yanlei email: yanleima@fudan.edu.cn organization: Fudan University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33660944$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1uEzEQxy1URD_gwgMgS1wQUoq99vrjglRFfKoVFzhbrnc2ceS1g72bKjcegWfkSXCaUEGF6out8e__nxnNnKKjmCIg9JySc1rPm5UbhnMqmJKP0AltVTPjmvGjw5sqpo7RaSkrQpigTD9Bx4wJQTTnJ2hzgWPaQMCw9uMSgrfh14-fAxSIbrkdbMBjtrH40aeIhxTATcFmXPwi2nHKgNcZOu_Ggqsap-hSSAvvqi5No0vVCPuId9EMbqxhZ6OD_BQ97m0o8Oxwn6Fv7999nX-cXX758Gl-cTlzXAo5U6KTkvWWKcZp32plBelUC9CBJJz0UjrWd5Twa961jiuiBbXU6o66TreMsjP0du-7nq4H6BzE2k4w6-wHm7cmWW_-_Yl-aRZpYxRhnLeyGrw6GOT0fYIymsEXByHYCGkqpuFaEi1Zs8v18h66SlOOtT3TCMlZS3mjH6RaShpB2G3aF3_XfVfwn8FV4PUecDmVkqG_Qygxu60wu60wt1tRYXIPdn60u5HWnn34v4TuJTc-wPYBc_N5fnW11_wGGNPM1A |
CitedBy_id | crossref_primary_10_1002_cam4_5384 crossref_primary_10_1186_s12876_022_02257_2 crossref_primary_10_18632_aging_204878 crossref_primary_10_18632_aging_205946 crossref_primary_10_1002_cam4_4568 crossref_primary_10_1007_s00432_022_04070_6 crossref_primary_10_1016_j_compbiomed_2023_106639 crossref_primary_10_1155_2023_5093941 |
Cites_doi | 10.1200/JCO.18.02258 10.1002/advs.201901380 10.3389/fonc.2020.00183 10.3322/caac.21551 10.1016/j.stem.2010.04.001 10.1038/s41568-019-0168-y 10.1038/s41580-018-0080-4 10.1038/nm.3967 10.3727/096504016X14685034103554 10.18632/oncotarget.13116 10.1200/JCO.2011.36.5080 10.1038/s41580-020-0237-9 10.1136/gutjnl-2018-316324 10.1016/j.ccell.2018.09.003 10.1016/j.ccr.2013.08.005 10.1158/0008-5472.CAN-14-0923 10.1053/j.gastro.2018.11.019 10.1038/nrclinonc.2017.44 10.1038/emboj.2010.351 10.3109/03009734.2011.638729 10.1038/nrc1740 10.1007/s00401-017-1757-z 10.1016/j.jgg.2019.11.010 10.1038/s41586-020-2394-6 10.18632/aging.102776 10.1016/j.jhep.2020.05.004 10.1038/nature16064 10.3390/genes5030536 10.1038/ncb3513 10.1016/j.bbrc.2016.11.126 10.1016/j.cell.2008.03.027 10.1038/s41568-019-0213-x 10.1073/pnas.1618091114 10.1007/s00384-012-1520-9 |
ContentType | Journal Article |
Copyright | 2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. – notice: 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. – notice: 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION NPM 3V. 7QP 7TK 7X7 7XB 88E 88I 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U RC3 7X8 5PM |
DOI | 10.1111/jcmm.16387 |
DatabaseName | Wiley-Blackwell Open Access Titles CrossRef PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Science Database Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database Publicly Available Content Database MEDLINE - Academic PubMed CrossRef |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | SHAN et al |
EISSN | 1582-4934 |
EndPage | 3204 |
ExternalDocumentID | PMC8034457 33660944 10_1111_jcmm_16387 JCMM16387 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: National Ten Thousand Plan Young Top Talents – fundername: Fudan University Excellence 2025 Talent Cultivation Plan – fundername: Shanghai Science and Technology Development Fund funderid: 19410713300; 20XD1421200 – fundername: CSCO‐Roche Tumor Research Fund funderid: Y‐2019Roche‐079 – fundername: Shanghai Young Top Talents funderid: QNBJ1701 – fundername: National Natural Science Foundation of China funderid: 81920108026; 81871964 – fundername: Shanghai Young Top Talents grantid: QNBJ1701 – fundername: National Natural Science Foundation of China grantid: 81920108026 – fundername: National Natural Science Foundation of China grantid: 81871964 – fundername: Shanghai Science and Technology Development Fund grantid: 19410713300 – fundername: CSCO-Roche Tumor Research Fund grantid: Y-2019Roche-079 – fundername: Shanghai Science and Technology Development Fund grantid: 20XD1421200 – fundername: National Natural Science Foundation of China grantid: 81920108026; 81871964 – fundername: CSCO‐Roche Tumor Research Fund grantid: Y‐2019Roche‐079 – fundername: ; grantid: 19410713300; 20XD1421200 |
GroupedDBID | --- 0R~ 1OC 24P 29K 31~ 36B 3V. 4.4 53G 5GY 5VS 7X7 8-0 8-1 88E 88I 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 AAHHS AAZKR ABUWG ACCFJ ACCMX ACGFS ACGOD ACXQS ADBBV ADKYN ADPDF ADRAZ ADZMN ADZOD AEEZP AENEX AEQDE AFBPY AFKRA AFZJQ AHMBA AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CAG CCPQU COF CS3 D-9 D-I DIK DU5 DWQXO E3Z EBD EBS EJD EMB EMOBN F5P FYUFA GNUQQ GODZA GROUPED_DOAJ HCIFZ HMCUK HYE HZ~ IAO IHR ITC KQ8 LH4 LK8 LW6 M1P M2P M48 M7P O9- OIG OK1 OVD OVEED PIMPY PQQKQ PROAC PSQYO Q2X RNS ROL RPM SV3 TEORI UKHRP WIN AAYXX ABJNI CITATION PHGZM PHGZT NPM 7QP 7TK 7XB 8FD 8FK AAMMB AEFGJ AGXDD AIDQK AIDYY FR3 K9. P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U RC3 7X8 5PM |
ID | FETCH-LOGICAL-c4767-86d773fa38341f598a60d85eede7040f77c3fd104b4d5c480961a1a9d1cd95313 |
IEDL.DBID | M48 |
ISSN | 1582-1838 1582-4934 |
IngestDate | Thu Aug 21 14:04:55 EDT 2025 Fri Jul 11 00:57:31 EDT 2025 Wed Aug 13 09:51:13 EDT 2025 Wed Aug 13 07:31:45 EDT 2025 Wed Feb 19 02:27:47 EST 2025 Tue Jul 01 01:35:15 EDT 2025 Thu Apr 24 23:06:17 EDT 2025 Wed Jan 22 16:29:49 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | colorectal cancer immunity risk score model prognosis epithelial-Mesenchymal Transition |
Language | English |
License | Attribution 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4767-86d773fa38341f598a60d85eede7040f77c3fd104b4d5c480961a1a9d1cd95313 |
Notes | Zezhi Shan, Wen Wu, Xuebing Yan and Yongzhi Yang contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-7121-8563 0000-0002-0632-5258 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1111/jcmm.16387 |
PMID | 33660944 |
PQID | 2510260357 |
PQPubID | 2034150 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8034457 proquest_miscellaneous_2497097321 proquest_journals_2674351429 proquest_journals_2510260357 pubmed_primary_33660944 crossref_primary_10_1111_jcmm_16387 crossref_citationtrail_10_1111_jcmm_16387 wiley_primary_10_1111_jcmm_16387_JCMM16387 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2021 |
PublicationDateYYYYMMDD | 2021-04-01 |
PublicationDate_xml | – month: 04 year: 2021 text: April 2021 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Chichester – name: Hoboken |
PublicationTitle | Journal of cellular and molecular medicine |
PublicationTitleAlternate | J Cell Mol Med |
PublicationYear | 2021 |
Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc |
References | 2013; 28 2013; 24 2020; 583 2019; 37 2011; 30 2019; 19 2015; 527 2020; 12 2020; 10 2017; 134 2017; 114 2020; 7 2016; 7 2014; 5 2019; 20 2017; 14 2020; 73 2019; 46 2019; 68 2019; 69 2015; 21 2005; 5 2017; 19 2017; 482 2020; 21 2014; 74 2018; 34 2008; 133 2011; 29 2012; 117 2010; 6 2016; 24 2019; 156 e_1_2_9_30_1 e_1_2_9_31_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_12_1 e_1_2_9_33_1 Cheng M (e_1_2_9_23_1) 2020; 10 e_1_2_9_15_1 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_20_1 e_1_2_9_22_1 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 e_1_2_9_28_1 e_1_2_9_27_1 e_1_2_9_29_1 |
References_xml | – volume: 69 start-page: 7 issue: 1 year: 2019 end-page: 34 article-title: Cancer statistics, 2019 publication-title: CA Cancer J Clin – volume: 30 start-page: 783 issue: 4 year: 2011 end-page: 795 article-title: TGF‐β regulates isoform switching of FGF receptors and epithelial‐mesenchymal transition publication-title: EMBO J – volume: 527 start-page: 525 issue: 7579 year: 2015 end-page: 530 article-title: Epithelial‐to‐mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer publication-title: Nature – volume: 7 start-page: 1901380 issue: 3 year: 2020 article-title: Targeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer publication-title: Adv Sci (Weinh) – volume: 74 start-page: 6330 issue: 21 year: 2014 end-page: 6340 article-title: Transient SNAIL1 expression is necessary for metastatic competence in breast cancer publication-title: Can Res – volume: 19 start-page: 454 issue: 8 year: 2019 end-page: 464 article-title: YAP and TAZ: a signalling hub of the tumour microenvironment publication-title: Nat Rev Cancer – volume: 20 start-page: 69 issue: 2 year: 2019 end-page: 84 article-title: New insights into the mechanisms of epithelial‐mesenchymal transition and implications for cancer publication-title: Nat Rev Mol Cell Biol – volume: 21 start-page: 1350 issue: 11 year: 2015 end-page: 1356 article-title: The consensus molecular subtypes of colorectal cancer publication-title: Nat Med – volume: 6 start-page: 603 issue: 6 year: 2010 end-page: 615 article-title: A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer publication-title: Cell Stem Cell – volume: 134 start-page: 923 issue: 6 year: 2017 end-page: 940 article-title: RNAi screen identifies essential regulators of human brain metastasis‐initiating cells publication-title: Acta Neuropathol – volume: 46 start-page: 595 issue: 12 year: 2019 end-page: 597 article-title: dbEMT 2.0: An updated database for epithelial‐mesenchymal transition genes with experimentally verified information and precalculated regulation information for cancer metastasis publication-title: J Genet Genomics – volume: 24 start-page: 347 issue: 3 year: 2013 end-page: 364 article-title: Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells publication-title: Cancer Cell – volume: 12 start-page: 2777 issue: 3 year: 2020 end-page: 2797 article-title: TP53/miR‐34a‐associated signaling targets expression in human pancreatic cancer publication-title: Aging (Albany NY) – volume: 29 start-page: 4796 issue: 36 year: 2011 end-page: 4802 article-title: Predicting survival after curative colectomy for cancer: individualizing colon cancer staging publication-title: J Clin Oncol – volume: 5 start-page: 536 issue: 3 year: 2014 end-page: 560 article-title: From genotype to functional phenotype: unraveling the metabolomic features of colorectal cancer publication-title: Genes (Basel) – volume: 24 start-page: 437 issue: 6 year: 2016 end-page: 445 article-title: Knockdown of SPOCK1 Inhibits the Proliferation and Invasion in Colorectal Cancer Cells by Suppressing the PI3K/Akt Pathway publication-title: Oncol Res – volume: 19 start-page: 518 issue: 5 year: 2017 end-page: 529 article-title: The EMT‐activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer publication-title: Nat Cell Biol – volume: 68 start-page: 1764 issue: 10 year: 2019 end-page: 1773 article-title: Tumour‐associated macrophages‐derived CXCL8 determines immune evasion through autonomous PD‐L1 expression in gastric cancer publication-title: Gut – volume: 34 start-page: 561 issue: 4 year: 2018 end-page: 578.e6 article-title: Complement C5a fosters squamous carcinogenesis and limits T cell response to chemotherapy publication-title: Cancer Cell – volume: 14 start-page: 611 issue: 10 year: 2017 end-page: 629 article-title: EMT, CSCs, and drug resistance: the mechanistic link and clinical implications publication-title: Nat Rev Clin Oncol – volume: 10 start-page: 183 year: 2020 article-title: Genomics and prognosis analysis of epithelial‐mesenchymal transition in glioma publication-title: Front Oncol – volume: 5 start-page: 899 issue: 11 year: 2005 end-page: 904 article-title: Opinion: the origin of the cancer stem cell: current controversies and new insights publication-title: Nat Rev Cancer – volume: 28 start-page: 9 issue: 1 year: 2013 end-page: 18 article-title: CD44v6, c‐Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk publication-title: Int J Colorectal Dis – volume: 21 start-page: 341 issue: 6 year: 2020 end-page: 352 article-title: Guidelines and definitions for research on epithelial‐mesenchymal transition publication-title: Nat Rev Mol Cell Biol – volume: 117 start-page: 143 issue: 2 year: 2012 end-page: 152 article-title: Tumor‐promoting functions of transforming growth factor‐β in progression of cancer publication-title: Ups J Med Sci – volume: 156 issue: 4 year: 2019 article-title: NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice publication-title: Gastroenterology – volume: 37 start-page: 1876 issue: 22 year: 2019 end-page: 1885 article-title: Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance) publication-title: J Clin Oncol – volume: 19 start-page: 716 issue: 12 year: 2019 end-page: 732 article-title: Controversies around epithelial‐mesenchymal plasticity in cancer metastasis publication-title: Nat Rev Cancer – volume: 583 start-page: 133 issue: 7814 year: 2020 end-page: 138 article-title: DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25 publication-title: Nature – volume: 482 start-page: 870 issue: 4 year: 2017 end-page: 876 article-title: SPOCK1 is up‐regulated and promotes tumor growth via the PI3K/AKT signaling pathway in colorectal cancer publication-title: Biochem Biophys Res Comm – volume: 114 start-page: 11494 issue: 43 year: 2017 end-page: 11499 article-title: Breast tumor cell‐specific knockout of inhibits cancer cell plasticity, dissemination, and lung metastasis in mice publication-title: Proc Natl Acad Sci USA – volume: 7 start-page: 85021 issue: 51 year: 2016 end-page: 85032 article-title: EGF induces epithelial‐mesenchymal transition through phospho‐Smad2/3‐Snail signaling pathway in breast cancer cells publication-title: Oncotarget – volume: 10 start-page: 403 issue: 2 year: 2020 end-page: 423 article-title: FLNA promotes chemoresistance of colorectal cancer through inducing epithelial‐mesenchymal transition and smad2 signaling pathway publication-title: Am J Cancer Res – volume: 73 start-page: 906 issue: 4 year: 2020 end-page: 917 article-title: Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma publication-title: J Hepatol – volume: 133 start-page: 704 issue: 4 year: 2008 end-page: 715 article-title: The epithelial‐mesenchymal transition generates cells with properties of stem cells publication-title: Cell – ident: e_1_2_9_15_1 doi: 10.1200/JCO.18.02258 – volume: 10 start-page: 403 issue: 2 year: 2020 ident: e_1_2_9_23_1 article-title: FLNA promotes chemoresistance of colorectal cancer through inducing epithelial‐mesenchymal transition and smad2 signaling pathway publication-title: Am J Cancer Res – ident: e_1_2_9_25_1 doi: 10.1002/advs.201901380 – ident: e_1_2_9_31_1 doi: 10.3389/fonc.2020.00183 – ident: e_1_2_9_2_1 doi: 10.3322/caac.21551 – ident: e_1_2_9_20_1 doi: 10.1016/j.stem.2010.04.001 – ident: e_1_2_9_37_1 doi: 10.1038/s41568-019-0168-y – ident: e_1_2_9_9_1 doi: 10.1038/s41580-018-0080-4 – ident: e_1_2_9_14_1 doi: 10.1038/nm.3967 – ident: e_1_2_9_26_1 doi: 10.3727/096504016X14685034103554 – ident: e_1_2_9_5_1 doi: 10.18632/oncotarget.13116 – ident: e_1_2_9_3_1 doi: 10.1200/JCO.2011.36.5080 – ident: e_1_2_9_4_1 doi: 10.1038/s41580-020-0237-9 – ident: e_1_2_9_32_1 doi: 10.1136/gutjnl-2018-316324 – ident: e_1_2_9_33_1 doi: 10.1016/j.ccell.2018.09.003 – ident: e_1_2_9_6_1 doi: 10.1016/j.ccr.2013.08.005 – ident: e_1_2_9_35_1 – ident: e_1_2_9_13_1 doi: 10.1158/0008-5472.CAN-14-0923 – ident: e_1_2_9_29_1 doi: 10.1053/j.gastro.2018.11.019 – ident: e_1_2_9_22_1 doi: 10.1038/nrclinonc.2017.44 – ident: e_1_2_9_7_1 doi: 10.1038/emboj.2010.351 – ident: e_1_2_9_8_1 doi: 10.3109/03009734.2011.638729 – ident: e_1_2_9_18_1 doi: 10.1038/nrc1740 – ident: e_1_2_9_30_1 doi: 10.1007/s00401-017-1757-z – ident: e_1_2_9_16_1 doi: 10.1016/j.jgg.2019.11.010 – ident: e_1_2_9_34_1 doi: 10.1038/s41586-020-2394-6 – ident: e_1_2_9_28_1 doi: 10.18632/aging.102776 – ident: e_1_2_9_36_1 doi: 10.1016/j.jhep.2020.05.004 – ident: e_1_2_9_12_1 doi: 10.1038/nature16064 – ident: e_1_2_9_17_1 doi: 10.3390/genes5030536 – ident: e_1_2_9_11_1 doi: 10.1038/ncb3513 – ident: e_1_2_9_27_1 doi: 10.1016/j.bbrc.2016.11.126 – ident: e_1_2_9_19_1 doi: 10.1016/j.cell.2008.03.027 – ident: e_1_2_9_21_1 doi: 10.1038/s41568-019-0213-x – ident: e_1_2_9_10_1 doi: 10.1073/pnas.1618091114 – ident: e_1_2_9_24_1 doi: 10.1007/s00384-012-1520-9 |
SSID | ssj0036139 |
Score | 2.3593915 |
Snippet | Epithelial‐mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour... Epithelial-mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3194 |
SubjectTerms | Clustering Colorectal cancer Colorectal carcinoma Epithelial cells epithelial‐Mesenchymal Transition Gene expression Growth factors immunity Lymph nodes Medical prognosis Mesenchyme Metastases Metastasis Microenvironments Multivariate analysis Nomograms Original Patients Principal components analysis Prognosis Regression analysis risk score model Software Statistical analysis Transcription factors Tumor microenvironment Tumors |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fS-QwEB9OjwNfxDvvtOodOfTlDnpubdokTyJyIsL6pLBvJU1SFLbtutsVfPMj-Bnvk9xMtq0uim8lmUCamcyfZPIbgAOnhLFC8xCNTRFyR9UApeXhwKpUFjqPDaeHwsPL9PyaX4ySUXvgNmvTKjud6BW1rQ2dkR-iHSb4qzgRx5O7kKpG0e1qW0JjBT4SdBmldIlRH3DFaKpUC0nqs3dMWf4h_0MsG6FXnuXrBMmXjqu3PGcbsN66jOxkwePP8MFVX-DToojkwybcn7Cqvndj5ib0vmKMAvXv8amkV0Xm5qHEkQ3ZI5-axcquGi6jxA0P6skmU7qsaWYMR7O6Mp06ZPW8wbVxM3ZbMWol5YjNhgRl-hWuz_5enZ6HbTWF0HCB2lCmVoi40BiS8qhIlNTpwMoEbaQTuJMLIUxcWIzOcm4TwyXVgtGRVjYyVuFOjb_BalVXbhuYtFIlWnFTqAG3OlW49Bhii9xxFeVWB_CrW97MtFDjVPFinPUhB7Ii86wIYL-nnSwANt6k2uu4lLWbbJY9i8Tb3fS-Av3BIxXAz74bdw9diejK1XOk4Up4wKIogK0Fz_tZxHGaYvDLAxBL0tATEDL3ck91e-MRuiUBKdK0fnu5eefHsovT4dB_7bz_i7uwdkTpND5paA9Wm-ncfUd_qMl_eKH_D44IDzg priority: 102 providerName: ProQuest – databaseName: Wiley-Blackwell Open Access Titles dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fS9xAEB-sIvSltGrbVFtW9EUh5XLZZHehLyIVEU58UPAtbHY3KFyS4y4n-NaP0M_YT-LM5g8e2kLfQnYWkp3_ycxvAA6dEsYKzUN0NkXIHU0DlJaHI6tSWeg8NpwahSeX6fkNv7hNbtfgR98L0-JDDB_cSDO8vSYF1_niuZKbsvxO0YR4AxvUW0vI-WN-1dvhGB2V8mipGEOi4MoOnNTX8Qx7V93RixjzZank8xDW-6Cz9_CuCx7ZScvtD7Dmqi3YbMdJPm7Dwwmr6gc3ZW5GnRZTFK0_v36X1F9k7h5L3NmQZ_JFWqzs5-IyKuHw8J5sNqffNs2C4W5WV6Y3jKxeNng8bsHuK0Z3yUzibUMiM9-Bm7Of16fnYTdXITRcoF2UqRUiLjQmpzwqEiV1OrIyQW_pBOp0IYSJC4t5Ws5tYrikqTA60spGxirU2fgjrFd15T4Dk1aqRCtuCjXiVqdKJRKTbZE7rqLc6gCO-uPNTAc6TrMvptmQfCArMs-KAA4G2lkLtfEq1V7PpaxTt0WGQRpho8XJX5ap0wIjw7EKYH9YRj2inyO6cvUSabgSHrooCuBTy_PhKeI4TTEN5gGIFWkYCAije3Wlur_zWN2SIBXpsY693PzjxbKL08nEX335H-JdeDumMhtfTLQH68186b5inNTk37w6PAFDDhJn priority: 102 providerName: Wiley-Blackwell |
Title | A novel epithelial‐mesenchymal transition molecular signature predicts the oncological outcomes in colorectal cancer |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjcmm.16387 https://www.ncbi.nlm.nih.gov/pubmed/33660944 https://www.proquest.com/docview/2510260357 https://www.proquest.com/docview/2674351429 https://www.proquest.com/docview/2497097321 https://pubmed.ncbi.nlm.nih.gov/PMC8034457 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1fi9QwEB_uD4Iv4n-r5xLRF4Ue223aJA8i63HHcbDHIVYWX0qbpNzBtl13u4f75kfwM_pJnMm2xeVO8aUtTQJpZiYz08z8BuCNVUIbkXEflU3hc0vVAKXh_tCoWBZZHmpOicKT8_g04WfTaLoDXf3OdgGXt7p2VE8qWcwOv39bf0CBf99H5eiyPCS7QuzCPmokQQI64f1pQogqSzncVLQmkYVlC1O6PXZbMd2wNm8GTf5pzDptdHIf7rVmJBtv6P4Admz1EO5sCkuuH8H1mFX1tZ0xO6ecixky2a8fP0vKNNKX6xJHNqSjXLgWK7sKuYyCORzQJ5sv6ACnWTIczepKd1skq1cN8qhdsquK0VvaMPG1JuZZPIbk5Pjz0anfVljwNRe4Q8rYCBEWGbqpPCgiJbN4aGSEetMKlO5CCB0WBj22nJtIc0n1YbIgUybQRqH0hk9gr6or-wyYNFJFmeK6UENuslipSKLbLXLLVZCbzIO33fKmuoUfpyoYs7R3Q5AUqSOFB6_7vvMN6MatvQ46KqUd36RorhFKWhj9pZlyLtBGHCkPXvXNKFF0TJJVtl5hH66EAzEKPHi6oXk_izCMY3SIuQdiixv6DoTWvd1SXV061G5J4Io0rXeOb_7xYenZ0WTinp7_10K8gLsjirSheCJxAHvNYmVfoqnU5APYHfELvIqpGMD--EvyNcH7x-Pzi08D9_th4CTlNybJG9I |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVAguiDeGAouAA0iGOF57vQeESmmVPhIh1Eq9GXt3rVaK7ZA4RbnxE_gl_Ch-CTPrB0SteuvN8q4t2_PtPLwz3wC8MlIoLRLuorHJXG6oG2CkudvXMoyyJPUVp0Lh0TgcHvG94-B4DX63tTCUVtnqRKuodanoH_l7tMNEf-UH4uP0u0tdo2h3tW2hUcNi3yx_YMg2_7D7GeX7ejDY2T7cGrpNVwFXcYFaIQq1EH6WYGjGvSyQURL2dRSgrTACEZ0JofxMY5SSch0oHlFPlMRLpPaUlohYH-97Dda5j6FMD9Y_bY-_fG11v4_GUTYkqDZfSOX5O_J4xKrZO-fLnk_J_N9VtrZu5zbcapxUtlmj6g6smeIuXK_bVi7vwdkmK8ozM2FmShUdE4Twn5-_cqpjUifLHK-syALaZDCWt_13GaWKWBpRNp3R9lA1Z3g1KwvVKmBWLiqUhpmz04LRWVLHeFoRNGf34ehKvvQD6BVlYR4Bi3Qkg0Rylck-10koZRBhUC9Sw6WX6sSBN-3njVVDbk49NiZxF-SgKGIrCgdednOnNaXHhbM2WinFzbKex_9AePEwVXSgBzqQDrzohnG90iZMUphygXO4FJYiyXPgYS3z7il8Pwwx3OYOiBU0dBOIC3x1pDg9sZzgEVE30mO9tbi55MXiva3RyB49vvwVn8ON4eHoID7YHe8_gZsDSuaxKUsb0KtmC_MUvbEqfdYsAQbfrnrV_QW8lkwj |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFH4qRaBeEDuBAkbAAaTAZOLE8QGhqmXUhak4UGluqWM7aqVJMp2laG78BH4PP4dfwnvOAqNWvfUWxU4U-31vi98C8MZKoY1Q3Edlk_vcUjfAxHC_Z2Sc5CoLNadE4eFhvHvE90fRaA1-t7kwFFbZykQnqE2l6R_5R9TDVP4qRAc-b8Iivu0MPk_OfOogRSetbTuNGiIHdvkD3bfZp70dpPXbfn_w5fv2rt90GPA1FyghktgIEeYK3TQe5JFMVNwzSYR6wwpEdy6EDnODHkvGTaR5Qv1RVKCkCbSRiN4Q33sDboowCojHxKhz9kJUk7Iph-oih3RRfCDbR6wqwAtW7cXgzP-NZqf1BnfhTmOusq0aX_dgzZb34VbdwHL5AM63WFmd2zGzE8rtGCOY__z8VVBGkz5ZFvjknHShCwtjRduJl1HQiCsoyiZTOiiazxg-zapSt6KYVYs50sXO2GnJ6C4JZrytCaTTh3B0Lfv8CNbLqrRPgCUmkZGSXOeyx42KpYwSdO9FZrkMMqM8eNdub6qbMufUbWOcdu4OkiJ1pPDgdTd3Uhf3uHTWZkultGHwWfoPjpcPU24H2qJ96cGrbhg5l45jVGmrBc7hUrhiSYEHj2uad18RhnGMjjf3QKygoZtAVcFXR8rTE1cdPKEijvRZ7x1urlhYur89HLqrp1cv8SXcRl5Lv-4dHjyDjT5F9bjYpU1Yn08X9jmaZfPshcM_g-PrZri_TrZO8w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+novel+epithelial%E2%80%90mesenchymal+transition+molecular+signature+predicts+the+oncological+outcomes+in+colorectal+cancer&rft.jtitle=Journal+of+cellular+and+molecular+medicine&rft.au=Shan%2C+Zezhi&rft.au=Wu%2C+Wen&rft.au=Yan%2C+Xuebing&rft.au=Yang%2C+Yongzhi&rft.date=2021-04-01&rft.issn=1582-1838&rft.eissn=1582-4934&rft.volume=25&rft.issue=7&rft.spage=3194&rft.epage=3204&rft_id=info:doi/10.1111%2Fjcmm.16387&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_jcmm_16387 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1582-1838&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1582-1838&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1582-1838&client=summon |